Citations

Institution: Mayo Clinic Clear

Showing 10 of 108135 citations.

Use of a preclinical model of pancreas cancer to identify potential candidates for rapalogue therapy
Takeuchi, Kenneth K., Crawford, Howard C, Crawford, Howard C.

Gut | June 26, 2014 | Volume: 63 | Issue: 9 | Pages: 1379-1380

10.1136/gutjnl-2014-307317 | PMID 24966285 Get It

Using Sit-Stand Workstations to Decrease Sedentary Time in Office Workers: A Randomized Crossover Trial
Dutta, Nirjhar , Koepp, Gabriel A., Stovitz, Steven D. , Levine, James A. , Pereira, Mark A. , Pereira, Mark A

International Journal of Environmental Research and Public Health | June 26, 2014 | Volume: 11 | Issue: 7 | Pages: 6653-6665

10.3390/ijerph110706653 | PMID 24968210 Get It

Objective: This study was conducted to determine whether installation of sit-stand desks (SSDs) could lead to decreased sitting time during the workday among sedentary office workers. Methods: A randomized cross-over trial was conducted from January to April, 2012 at a business in Minneapolis. 28 (nine men, 26 full-time) sedentary office workers took part in a 4 week intervention period which included the use of SSDs to gradually replace 50% of sitting time with standing during the workday. Physical activity was the primary outcome. Mood, energy level, fatigue, appetite, dietary intake, and productivity were explored as secondary outcomes. Results: The intervention reduced sitting time at work by 21% (95% CI 18%–25%) and sedentary time by 4.8 min/work-hr (95% CI 4.1–5.4 min/work-hr). For a 40 h work-week, this translates into replacement of 8 h of sitting time with standing and sedentary time being reduced by 3.2 h. Activity level during non-work hours did not change. The intervention also increased overall sense of well-being, energy, decreased fatigue, had no impact on productivity, and reduced appetite and dietary intake. The workstations were popular with the participants. Conclusion: The SSD intervention was successful in increasing work-time activity level, without changing activity level during non-work hours.
Identification and lateral membrane localization of cyclin M3, likely to be involved in renal Mg2+handling in seawater fish
Islam, Zinia, Hayashi, Naoko, Inoue, Hana, Umezawa, Takahiro, Kimura, Yuuri, Doi, Hiroyuki , Romero, Michael F. , Hirose, Shigehisa , Kato, Akira , Inoue, Hana, Romero, Michael F , Kato, Akira

American Journal of Physiology-Regulatory, Integrative and Comparative Physiology | June 26, 2014 | Volume: 307 | Issue: 5 | Pages: R525-R537

10.1152/ajpregu.00032.2014 | PMID 24965791 Get It

The kidney of marine teleosts is the major site of Mg2+excretion and produces urine with a high Mg2+concentration. However, the transporters involved in Mg2+excretion are poorly understood. The cyclin M (Cnnm; also known as ancient conserved domain protein) family comprises membrane proteins homologous to the bacterial Mg2+and Co2+efflux protein, CorC. To understand the molecular mechanism of Mg2+homeostasis in marine teleosts, we analyzed the expression of the C nnm family genes in the seawater (SW) pufferfish, torafugu ( Takifugu rubripes), and the closely related euryhaline species, mefugu ( Takifugu obscurus). Database mining and phylogenetic analysis indicated that the Takifugu genome contains six members of the Cnnm family: two orthologs of Cnnm1, one of Cnnm2, one of Cnnm3, and two of Cnnm4. RT-PCR analyses indicated that Cnnm2, Cnnm3, and Cnnm4a are expressed in the kidney, whereas other members are mainly expressed in the brain. Renal expression of Cnnm3 was upregulated in SW mefugu, whereas renal expression of Cnnm2 was upregulated in freshwater (FW) mefugu. No significant difference was observed in renal expression of Cnnm4a between SW and FW mefugu. In situ hybridization and immunohistochemical analyses of the SW mefugu kidney revealed that Cnnm3 is expressed in the proximal tubule, and its product localizes to the lateral membrane. When Cnnm3 was expressed in Xenopus laevis oocytes, whole cellular Mg2+content and free intracellular Mg2+activity significantly decreased. These results suggest that Cnnm3 is involved in body fluid Mg2+homeostasis in marine teleosts.
Atrial Fibrillation in Hypertrophic Cardiomyopathy: Prevalence, Clinical Correlations, and Mortality in a Large High‐Risk Population
Siontis, Konstantinos C. , Geske, Jeffrey B. , Ong, Kevin , Ommen, Steve R. , Nishimura, Rick A. , Gersh, Bernard J. , Geske, Jeffrey B

Journal of the American Heart Association | June 26, 2014 | Volume: 3 | Issue: 3 | Pages: No page available

10.1161/jaha.114.001002 | PMID 24965028 Get It

Background Atrial fibrillation ( AF ) is a common sequela of hypertrophic cardiomyopathy ( HCM ), but evidence on its prevalence, risk factors, and effect on mortality is sparse. We sought to evaluate the prevalence of AF , identify clinical and echocardiographic correlates, and assess its effect on mortality in a large high‐risk HCM population. Methods and Results We identified HCM patients who underwent evaluation at our institution from 1975 to 2012. AF was defined by known history (either chronic or paroxysmal), electrocardiogram, or Holter monitoring at index visit. We examined clinical and echocardiographic variables in association with AF . The effect of AF on overall and cause‐specific mortality was evaluated with multivariate Cox proportional hazards models. Of 3673 patients with HCM , 650 (18%) had AF. Patients with AF were older and more symptomatic ( P <0.001). AF was less common among patients with obstructive HCM phenotype and was associated with larger left atria, higher E/e’ ratios, and worse cardiopulmonary exercise tolerance (all P values<0.001). During median (interquartile range) follow‐up of 4.1 (0.2 to 10) years, 1069 (29%) patients died. Patients with AF had worse survival compared to those without AF ( P <0.001). In multivariate analysis adjusted for established risk factors of mortality in HCM , the hazard ratio (95% confidence interval) for the effect of AF on overall mortality was 1.48 (1.27 to 1.71). AF did not have an effect on sudden or nonsudden cardiac death. Conclusions In this large referral HCM population, approximately 1 in 5 patients had AF . AF was a strong predictor of mortality, even after adjustment for established risk factors.
Reply
Khosroshahi, Arezou , Cheryk, Lynn A., Bloch, Donald B. , Stone, John H., Stone, John H.

Arthritis & Rheumatology | June 25, 2014 | Volume: 66 | Issue: 11 | Pages: 3247-3248

10.1002/art.38751 | PMID 24965491 Get It

Delayed‐Onset Ulnar Neuritis After Release of Elbow Contracture: Preventive Strategies Derived From a Study of 563 Cases
Blonna, Davide , O’Driscoll, Shawn W. , Fitzsimmons, James S

Arthroscopy | June 25, 2014 | Volume: 30 | Issue: 8 | Pages: 947-956

10.1016/j.arthro.2014.03.022 | PMID 24974167 Get It

Purpose The purposes of this study were to determine whether delayed‐onset ulnar neuritis (DOUN) after elbow contracture release can be prevented and to compare the efficacy of ulnar nerve decompression versus subcutaneous transposition. Methods A retrospective study of 563 consecutive arthroscopic elbow contracture releases was conducted. The prophylactic efficacy of (1) subcutaneous transposition, (2) ulnar nerve decompression, (3) limited ulnar nerve decompression (7 to 8 cm), and (4) mini‐decompression (4 to 6 cm) was assessed prospectively. The efficacy of prophylactic strategies (transposition, decompression, limited decompression, or mini‐decompression) in preventing DOUN was compared by univariate survival analysis. Patients who underwent a subcutaneous transposition were matched with patients who underwent a standard open decompression or a limited decompression, according to gender, age (±10 years), diagnosis, and preoperative motion. This analysis was repeated after we excluded the patients who underwent associated open procedures (e.g., hardware removal). Results DOUN occurred in 26 of 235 patients (11%) who did not undergo any prophylactic procedure versus 8 of 295 patients (3%) who underwent a prophylactic ulnar nerve decompression or transposition at the time of contracture release ( P < .001). The neurologic impairment was significantly less severe after prophylactic decompression compared with patients without any prophylactic intervention (grade on Neuropathy Grading Scale, 2 v 4; P = .03). Ulnar nerve transposition and decompression were equally protective. The decompression length was the only factor significantly related to the failure of the prophylactic intervention (odds ratio, 0.19; P = .02). A mini‐decompression was not as effective as a prophylactic procedure, whereas a limited decompression was equal to a standard decompression. The case‐control analysis showed that the decompression and transposition had equal preventive effects but the transposition was associated with a higher rate of wound complications (19% v 4%, P = .03). Conclusions DOUN is a complication of arthroscopic elbow contracture release. Its incidence and severity can be reduced by limited open ulnar nerve decompression or transposition. Level of Evidence Level II, prospective comparative study with retrospective analysis.
Basosquamous carcinoma and metatypical basal cell carcinoma: a review of treatment with Mohs micrographic surgery
Allen, Kattie J., Cappel, Mark A. , Killian, Jill M. , Brewer, Jerry D.

International Journal of Dermatology | June 25, 2014 | Volume: 53 | Issue: 11 | Pages: 1395-1403

10.1111/ijd.12587 | PMID 24961583 Get It

AbstractBackgroundBasosquamous carcinoma (BSC) and metatypical basal cell carcinoma (MBCC) are uncommon tumors poorly defined in the literature. Available studies suggest these tumors carry a greater risk of recurrence and metastases than basal cell carcinomas (BCCs) and, in some studies, squamous cell carcinomas. Formal treatment recommendations are not fully established.ObjectiveTo analyze BSC and MBCC separately, evaluate whether they are distinct tumor subtypes, and analyze Mohs micrographic surgery (MMS) efficacy for BSC and MBCC.MethodsRetrospective review of medical records and histologic specimens was conducted for 293 patients with 303 biopsy‐proven BSCs or MBCCs treated with MMS between 1996 and 2004. In total, 32 BSCs and 128 MBCCs were identified. Surgical and follow‐up data were analyzed.ResultsKaplan–Meier estimates of recurrence‐free survival after MMS were 100% at one year for both tumor subtypes and were 100% for BSC and 93.8% for MBCC at 5 years. Initial mean sizes were 1.5 cm for BSC and 1.3 cm for MBCC. Approximately 7% represented recurrent tumors at surgery. Of six patients with recurrences, none had known metastatic disease.LimitationsLimitations include retrospective design, analysis of only head and neck sites, and small sample sizes.ConclusionBSC and MBCC showed no significant distinguishing characteristics to separate them into two BCC subtypes. Reported recurrence rates for BSC and MBCC are 12–45% with wide local excision; estimated recurrence rates are 4.1% with MMS. Our study showed recurrence‐free survival of 95.1% at five years. Hence, MMS is effective in treating these BCC subtypes.
A Review of the Application of Inflammatory Biomarkers in Epidemiologic Cancer Research
Brenner, Darren R. , Scherer, Dominique , Muir, Kenneth , Schildkraut, Joellen M. , Spitz, Margaret R., Goode, Ellen L. , Ulrich, Cornelia M. , Hung, Rayjean J., Hung, Rayjean J. , Boffetta, Paolo , Marchand, Loı̈c Le , Chan, Andrew T. , Hung, Rayjean J., Hung, Rayjean J , Muir, Kenneth

Cancer Epidemiology, Biomarkers & Prevention | June 25, 2014 | Volume: 23 | Issue: 9 | Pages: 1729-1751

10.1158/1055-9965.epi-14-0064 | PMID 24962838 Get It

Abstract Inflammation is a facilitating process for multiple cancer types. It is believed to affect cancer development and progression through several etiologic pathways, including increased levels of DNA adduct formation, increased angiogenesis, and altered antiapoptotic signaling. This review highlights the application of inflammatory biomarkers in epidemiologic studies and discusses the various cellular mediators of inflammation characterizing the innate immune system response to infection and chronic insult from environmental factors. Included is a review of six classes of inflammation-related biomarkers: cytokines/chemokines, immune-related effectors, acute-phase proteins, reactive oxygen and nitrogen species, prostaglandins and cyclooxygenase-related factors, and mediators such as transcription factors and growth factors. For each of these biomarkers, we provide a brief overview of the etiologic role in the inflammation response and how they have been related to cancer etiology and progression within the literature. We provide a discussion of the common techniques available for quantification of each marker, including strengths, weaknesses, and potential pitfalls. Subsequently, we highlight a few under-studied measures to characterize the inflammatory response and their potential utility in epidemiologic studies of cancer. Finally, we suggest integrative methods for future studies to apply multifaceted approaches to examine the relationship between inflammatory markers and their roles in cancer development. Cancer Epidemiol Biomarkers Prev; 23(9); 1729–51. ©2014 AACR.
Use of JAK inhibitors in the management of myelofibrosis: a revision of the British Committee for Standards in Haematology Guidelines for Investigation and Management o
Reilly, John T., Beer, Philip , Butt, Nauman M., Conneally, Eibhlin , Duncombe, Andrew , Green, Anthony R. , Mikhaeel, G., Gilleece, Maria , Knapper, Steven , Mead, Adam J. , Sekhar, Mallika , Harrison, Claire , McMullin, Mary Frances , Mesa, Ruben A. , Mead, Adam J , Knapper, Steven

British Journal of Haematology | June 25, 2014 | Volume: 167 | Issue: 3 | Pages: 418-420

10.1111/bjh.12985 | PMID 24961987 Get It